Federal Register
Notice: FDA has determined that Peptavlon (pentagastrin) for subcutaneous injection, 0.25 mg/mL, was not withdrawn from sale for reasons of safety or effectiveness. This determination will allow FDA to approve ANDAs for pentagastrin for subcutaneous injection, 0.25 mg/mL. To view this notice, click here.